Angina pectoris
Conditions
Sponsors
chibanishi general hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Men and women 20 years of age or older. 2) Patients who have chest pain even under standard medication. 3) Patients with no indication of revascularization (PCI or CABG), or patients in whom eonugh improvement is not expected compared to the risk of revascularization. 4) Canadian Cardiovascular Society (CCS) classification, Class II-IV patients. 5) Evidence of myocardial ischemia with myocardial stress-scintigraphy or stress MRI
Exclusion criteria
Exclusion criteria: 1) Patients whose target area cannot be observed with echocardiography. 2) Post-breast augmentation surgery with silicon pad. 3) Patients with prosthetic valve (mechanical valve) in the heart. 4) Q-wave myocardial infarction within 3 months. 5) Non-Q-wave myocardial infarction within 6 weeks. 6) Less than 1 month after the last revascularization (PCI or CABG). 7) Patients with cardiogenic shock or worsening heart failure (who require continuous infusion of cardiovascular agents such as inotropic agents or vasodilators). 8) Intracardiac thrombus. 9) Patients whose clinical status changed after the last coronary angiography. 10) Unstable diabetic retinopathy. 11) Patients who have malignancy or who have undergone surgery because of malignancy within the past five years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency in use of nitroglycerin per week. Evaluated at 3 month after the therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| CCS class scores, Exercise tolerance, Myocardial perfusion. Evaluated at 3 month after the therapy. | — |
Countries
Japan
Outcome results
None listed